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Abstract
Background: The city of Doha in Qatar has a high density of feral cats and there is a high risk of
toxoplasmosis for the resident human population. No data currently exist for the prevalence of
infection with Toxoplasma gondii in the city.
Methods: We analysed the serological response to Toxoplasma gondii of 1625 subjects referred
for routine hospital based serological tests in Doha, Qatar. Prevalence of current/recent infection
was assessed through an enzyme-linked immunosorbent assay (ELISA) for the presence of specific
anti-T. gondii IgM antibodies, and previous history of infection through IgG.
Results: Overall prevalence of IgG responses was 29.8% and this did not differ between the sexes
nor between the three years of the study although there was a marked age effect. Among children
less than 1 year old prevalence was 22.9%, but then dropped to <4% in the 1 year old group,
indicating that these antibodies were most likely acquired in utero from immune mothers.
Prevalence then increased steadily to peak at 41.2% among the oldest age class (>45 years). The
prevalence of IgG antibody also varied significantly with region of origin, with higher rates for
subjects from Africa, followed by those from the Eastern Mediterranean or Asia and lowest rates
for subjects from the Arabian Peninsula. No IgM antibodies were detected in any subjects younger
than 19 years, but prevalence increased to plateau at 7 – 9% in subjects aged over 20 years, and
also varied with region of origin. In this case prevalence was highest among subjects from the
Arabian Peninsula and least among those from Asia. Prevalence of IgM was higher among male
subjects but did not vary between the three years of the study.
Conclusion:  Although these data are based on a selected subset of the population, they
nevertheless provide the first evidence that toxoplasmosis is endemic in Qatar in the human
population, and that both age and region of origin play a role in the epidemiology of the infection.
Concerns relating to the role of high density of feral cats in sustaining the infection were
highlighted.
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Background
Toxoplasmosis is a cosmopolitan disease arising from
infection with the cat-borne Apicomplexan, coccidian
protozoan Toxoplasma gondii, an obligate intracellular par-
asite that forms cysts in mammalian tissues throughout
the body [1].
T. gondii has a worldwide distribution in human popula-
tions infecting up to one third of the global population
and a wide range of other mammalian and avian species
[2-7]. Toxoplasmosis is a major public health problem,
with a high socioeconomic impact in terms of human suf-
fering including the cost of caring for sick, mentally
retarded and blind children [8]. The parasite is an
extremely successful pathogen, responsible for significant
morbidity and mortality, especially in congenitally
infected and immuno-compromised individuals [4,9-11],
although some subjects experience infection without
overt disease or with mild symptoms [12,13]. On farms,
T. gondii is a major cause of abortion and problems with
fertility in livestock, especially among ewes [14], and
therefore a significant cause of lost profitability in live-
stock agriculture [15-17].
The most important channels for transmission to humans
are by ingestion of food or water contaminated with
oocysts shed by cats, by eating undercooked or raw meat
containing infective tissue cysts and via transplacental
transfer, notably when the mother becomes infected for
the first time during pregnancy [1,3,4,6,13,18-20].
Human infection with T. gondii is a huge challenge for
which there is no effective treatment.
Toxoplasmosis is a zoonosis arising from man's close con-
tact with domestic cats (Felis catus) [21,22]. Both domestic
and wild felids are the only known definitive hosts of T.
gondii in which the sexual cycle can take place [23], and
hence cats play a central role in the epidemiology of T.
gondii, constituting the only known source of environ-
mental contamination with the infective oocyst stage [2].
A high risk is thus imposed on human communities that
come into contact with cats [6].
As in many cities throughout the world, Doha in Qatar
has had a significant rodent problem for decades and it
was the difficulties in controlling these rodents that led to
a solution based on the introduction of cats in the 1960s,
but without any consideration of the possible knock-on
effects for human health. Introduced cats have multiplied
and colonized rapidly around food and water resources,
mainly in urban but also in rural areas. They are known to
harbour a range of helminths [24,25] and most likely also
protozoa and other infectious organisms, although no
surveys of the latter have been reported as yet. Cats are
only rarely kept as pets in Qatar, and yet the feline popu-
lation is believed to exceed 2 million, the vast majority liv-
ing on the streets, scavenging garbage as well as feeding on
the rodents. In the city of Doha and its surroundings,
these cats mostly have a feral existence congregating near
human dwellings, businesses, restaurants and in the mar-
ket places where food for human consumption is pre-
pared and traded. Because of the numbers involved Doha
city has introduced a control program, but there are no
plans to eliminate cats since they are believed to play a
vital role in keeping down rodents populations.
This unusual high density of cats in Doha presents an
obvious risk of infection to the human population and
toxoplasmosis would be expected [6]. However, despite
the acknowledged importance of T. gondii, surprisingly no
report has been published yet on the incidence of toxo-
plasmosis in man or its prevalence in cats in Qatar. In this
paper we report for the first time the prevalence of anti-
bodies to T. gondii in the sera of a subset of the human
population in Doha, subjects referred for serological test-
ing in hospital. We analysed the overall prevalence of anti-
bodies and also prevalence in relation to the available
demographic variables of the subjects, including their eth-
nic origin, because the population of Qatar is extremely
cosmopolitan with large numbers of immigrant workers
from Asia, Africa, and other Arabian Peninsula and East-
ern Mediterranean countries
Methods
Study location, selection of subjects and inclusion criteria
Doha is the capital city of Qatar, located in the Persian
Gulf, having a population of about 1 million in 2007 and
consisting of administrative, commercial, industrial and
residential areas, with patches of agricultural land that are
mostly grass fields.
The subjects for this study were 1625 individuals who had
been referred for the routine TORCH series of serological/
microbiological tests (Toxoplasma, Rubella, Cytomegalovi-
rus and Herpes), because they had been diagnosed with
one or more of the following: recent spontaneous abor-
tion, ocular infection, liver cirrhosis, jaundice, hepato-
splenomegaly. Mothers with a previous history of any one
or more of these conditions were also tested routinely dur-
ing pregnancy, and their most recent child usually within
a year of birth. We used data that had been collected in
hospitals in the period 2005–2007.
Sample collection
Blood samples were obtained from subjects referred for
examination in out-patients clinics by medically trained
staff. Confidentiality was maintained throughout and the
identity of subjects was not available to us, other than
through their reference number, and information on age,
sex and ethnic origin. The subjects were referred to theParasites & Vectors 2008, 1:39 http://www.parasitesandvectors.com/content/1/1/39
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phlebotomy unit for whole blood collection (5 ml) by
venipuncture in plain tubes. The blood samples were then
transported to the Virology laboratory at Hamad Medical
Corporation according to hospital arrangements. Blood
samples were centrifuged to remove blood cells and
stored at +4°C for 48 hours or frozen at -20°C for longer
storage. The study was approved by Medical Research
Center & Research Committee at Hamad Medical Corpo-
ration, Qatar (Research protocol # 8036/08).
Serological testing for toxoplasmosis
T. gondii infections in humans can only be detected by
antibody levels and the current analysis is based on the
prevalence of T. gondii specific IgG (evidence of earlier
infection, peaking at 4 months after infection and persist-
ing at low levels for life) and on T. gondii specific IgM (evi-
dence of current infection, appearing within 1–2 weeks of
infection and subsiding by 6–9 months[7]).
IgG
We used the commercially available Enzygnost*Toxoplas-
mosis/IgG kit from Dade Behring Inc. USA, and followed
the manufacturer's instructions. Briefly, all samples,
including the T. gondii positive (P/N) and negative (N/N)
reference samples were first diluted in a ratio of 1:20 using
the coloured sample buffer POD (0.3 mol/L Tris/HCl
buffer solution) and mixed well. Samples were then
added to the Enzygnost* Toxoplasmosis/IgG test plates
together with both positive and negative controls as per
instructions. The plates were sealed with foil and incu-
bated at 37°C for 60 mins. Then all the wells were washed
four times with the diluted washing solution POD and
after completion of the wash cycles, the wells were filled
with 100 μl of a 1:50 dilution of anti-human-IgG/POD
(enzyme conjugated- Fab fragment of rabbit antibody to
human IgG in Conjugate Buffer Microbiol (37 mg of
EDTA in a litre of 0.01 mol/L phosphate buffer solution).
The plates were sealed with foil and placed immediately
into the incubator (37°C for 60 mins.). Next the wells
were washed 4 times with diluted washing solution POD
(1:20 dilution of Washing Solution POD (Phosphate
buffered) with distilled water). After completing the wash
cycles, the wells were filled with 100 μl of working chro-
mogen solution (1 ml of Chromogen TMP (tetramethyl-
benzidine dihydrochloride) with 10 ml of buffer/
Substrate TMB (hydrogen peroxide) and sealed with fresh
foil. The plate was incubated immediately at room tem-
perature (15–25°C) for 30 mins, protected from light.
Finally 100 μl of stopping solution POD were added to
each well and kept at room temperature for 30 mins.
Results were quantified in the photometer at 450 nm
within 1 hour.
IgM
IgM antibody levels were quantified using the commer-
cially available Enzygnost*Toxoplasmosis/IgM assay
(Dade Behring, U.S.A), and by following the manufac-
turer's instructions. Essentially the assay was conducted as
for IgG except that a goat antibody to human IgM was
used to detect IgM bound to the plates.
Preparation of data for analysis
All birth dates and dates of examination were recorded
meticulously, and the ages of subjects were calculated to
the nearest month (for those below 3 years of age) and to
the nearest year for those older. Seven age classes were
then constructed but these did not span comparable age
ranges because we wished to scrutinise particularly care-
fully prevalence of antibody in children less than one year
of age and those from 12 to 24 months old. Other classes
were constructed to span young children (2–10 years) and
teenagers (11–20 years), and then young (21–29 years),
middle aged (30–45 years) and older (>45 years) subjects
in the sample.
The subjects or their parents (in the case of young chil-
dren) in this study came from 41 countries. For the pur-
pose of analysis these were grouped into 4 regions. These
were as follows (in parenthesis we give the percentage of
total sample for each country of origin, if more than
0.1%):
Arabian Peninsula (Bahrain (0.7%), Kuwait, Oman
(0.7%), Qatar (32.4%), Saudi Arabia (1.4%), United Arab
Emirates (0.4%) and Yemen (3.1%)).
Africa (Algeria (0.3%), Egypt (11.7%), Eritrea (0.1%),
Ethiopia (0.4%), Kenya, Libya (0.1%), Mauritania
(0.25%), Morocco (0.5%), Senegal, Somalia (0.7%), S.
Africa, Sudan (3.3%), Tunisia (1.0%)).
Eastern Mediterranean area (Jordan (5.5%), Lebanon
(1.0%), Palestine (9.8%), Syria (3.0%), Turkey (0.2%)).
Asia (Afghanistan, Bangladesh (1.4%), India (11.3%),
Indonesia (1.5%), Iran (1.4%), Iraq (1.3%), Macao,
Nepal (2.2%), N. and S. Korea, Malaysia, Pakistan, Philip-
pines (3.0%), Sri Lanka (1.4%), Thailand, Vietnam).
Statistical analysis
On the basis of the ELISA, subjects were diagnosed as
either positive/negative for specific IgG and IgM antibod-
ies to T. gondii. Prevalence data (percentage of subjects
showing a positive ELISA) are shown with 95% confi-
dence limits, calculated as described by Rohlf & Sokal [26]
employing bespoke software. We used a two stage method
for the analysis. Firstly the data were analyzed by maxi-
mum likelihood on log linear analysis of contingencyParasites & Vectors 2008, 1:39 http://www.parasitesandvectors.com/content/1/1/39
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tables using the software package SPSS (Version 12.0.1.).
Full factorial models incorporated age (7 age classes cor-
responding to : up to one year, one year, two to 10 years,
11–20, 21–29, 30–45, more than 45 years), sex (2 levels,
males and females), ethnic origin (four levels Arabian
Peninsula, African, Eastern Mediterranean and Asian) and
year of study (3 levels, 2005, 2006, and 2007). Evidence
of infection by the ELISA was considered as a binary factor
(present/absent of Toxoplasma specific antibody). Begin-
ning with the most complex model, involving all possible
main effects and interactions, those combinations that
did not contribute significantly to explaining variation in
the data were eliminated in a stepwise fashion beginning
with the highest-level interaction. A minimum sufficient
model was then obtained, for which the likelihood ratio
of χ2 was not significant, indicating that the model was
sufficient in explaining the data. The importance of each
term (i.e. interactions involving presence/absence of anti-
body) in the final model was assessed by the probability
that its exclusion would alter the model significantly and
these values are given in the text.
We also fitted general linear models (GLM) with quasibi-
nomial errors (because there was a disparity between
residual degrees of freedom and residual deviance in
models fitted with binomial errors) implemented in R
version 2.2.1 (R Core Development Team). Full factorial
models (with age class, sex, region of origin and year of
study, fitted as fixed factors with levels identical to those
specified above) that converged satisfactorily were simpli-
fied stepwise by deletion of terms beginning with the
highest order interaction and were evaluated by compar-
ing models with or without that interaction or main effect.
Changes in deviance were interpreted with χ2 tests. Mini-
mum sufficient models were then fitted (all significant
interactions and main effects + any main effects that fea-
tured in interactions) and the process was repeated to
obtain values for changes in deviance, test statistics and
probabilities.
Results
Demography of the study population
The study comprised 1625 subjects (1077 females and
548 males). Table 1 shows the distribution of subjects
among the age classes that were constructed for the pur-
pose of analysis of age effects. Although 338 children less
than one year old were tested, the numbers of 1 year old
children and 2–10 years old were very low by comparison
with other age classes. Table 1 also shows the distribution
of subjects by region of origin. Most subjects came from
countries in the Arabian Peninsula including Qatar itself
and its close neighbours, and fewest from the Eastern
Mediterranean region, but most categories were suffi-
ciently well represented to enable statistical analysis.
Prevalence of IgG antibody responses
A total of 484 subjects were found to be positive for IgG
antibodies, corresponding to 29.8% of the study group.
When other factors had been taken into consideration,
there was no significant difference between the sexes
(males = 27.6%, Cl95 = 24.7 – 30.6% and females =
30.9%, Cl95 = 31.1 – 37.0%), and no significant difference
between the three years of the study (2005 = 32.2%, Cl95
= 29.3 – 35.4%; 2006 = 28.6%, Cl95 = 22.8 – 35.0%; 2007
= 28.5%, Cl95 = 25.5 – 31.7%).
Figure 1 presents the distribution of prevalence with T.
gondii among different age groups (1a) and among sub-
jects from different ethnic regions in 2005–2007 (1b).
Analysis revealed a significant interaction between age
and region of origin (region of origin*age class* presence
of IgG, χ2
18 = 34.9, P = 0.01) and these data are illustrated
in Fig. 1c. The prevalence of positives among the newborn
children was 21.9% but then dropped markedly to the
lowest values in the one year old children despite the
smaller sample size of this age class (only 1 positive from
29 subjects). Prevalence then climbed steadily with each
subsequent age class, peaking among the oldest subject
(>45 years old) at 41.2%. When the age classes were
pooled, the highest prevalence of positives was among
subjects with an African origin (Fig. 1b, 40.1%) and low-
est among those from Arabian Peninsula countries (Fig.
1b, 25.0%). Figure 1c shows that positives were detected
in the youngest age class in all four groups, and that in all
four groups positives were rare in the age classes spanning
1 to 10 years. In all four groups positives were then seen
with increasing frequency as subjects aged, except for a dip
in the 21–29 year age class among subjects of an Eastern
Mediterranean origin. The lowest percentage of positives
was seen among middle aged and older subjects from
Asia. Thus, although the age-prevalence pattern was
clearly evident and generally similar in all four groups, it
Table 1: Numbers of subjects enrolled in the study by sex and 
age class
By sex By region of origin1
Age class2 M a l e s F e m a l e s 1234T o t a l
<1 yr 179 159 168 45 30 95 338
1 year 17 12 14 7 6 2 29
2–10 28 35 21 13 11 18 63
11–20 28 61 54 10 14 11 89
21–29 79 340 155 92 44 128 419
30–45 134 405 169 116 67 187 539
>45 83 65 49 21 8 70 148
Totals 548 1077 630 304 180 511 1625
1. Region 1 = Arabian Peninsula, 2 = Africa, 3 = Eastern 
Mediterranean, 4 = Asia.
2. Age range in each of the age classes used for analysisParasites & Vectors 2008, 1:39 http://www.parasitesandvectors.com/content/1/1/39
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Seroprevalence of anti Toxoplasma gondii IgG antibodies in subjects in Qatar Figure 1
Seroprevalence of anti Toxoplasma gondii IgG antibodies in subjects in Qatar. A. By age class. The number of subject 
in each age class in the order as shown on the abscissa (from age class <1 through to age class >45) was 338, 29, 63, 419, 539 
and 148 respectively. The total sample size was 1625. B. By region of origin. The number of subjects of each ethnic origin was 
as follows Arabian Peninsula = 630, Africa = 304, Eastern Mediterranean = 180 and Asia = 511. C. By age class and region of 
origin.Parasites & Vectors 2008, 1:39 http://www.parasitesandvectors.com/content/1/1/39
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nevertheless showed some variation between subjects of
different ethnic origin.
Analysis by R, fitting a GLM with a quasibinomial error
structure, confirmed the highly significant main effects of
age (change in deviance = 84.45, P < 0.0001, for 6 df) and
region (change in deviance = 27.03, P < 0.0001, for 3 df),
and the 2-way interaction between age and region (change
in deviance = 34.85, P = 0.01, for 18 df, residual degrees
of freedom = 1615).
Prevalence of IgM antibody responses
IgM antibody was detected less frequently than IgG with a
total of 94 subjects giving a positive ELISA (5.8%). With
other factors taken into consideration, there was no signif-
icant change in the prevalence of positive subjects across
the three years of the study despite an apparent downward
trend across the period (2005 = 7.4%, Cl95 = 5.8 -9.4%;
2006 = 5.6%, Cl95 = 3.1 – 9.6%; 2007 = 4.4%, Cl95 = 3.1 –
6.1%), representing a drop of 3%.
Figure 2 shows the epidemiological correlates of T. gondii
infection in men and women, among different age group
and from different ethnic origins. Analysis by maximum
likelihood revealed a simple minimum sufficient model
with just three main effects. Thus prevalence of subjects
with IgM for T. gondii, varied independently in relation to
ethnic origin (region of origin* presence of IgM, χ2
3 =
31.1, P < 0.001) and age (age class* presence of IgM, χ2
6
= 77.5, P < 0.001). The strongest effect was that of age. No
T. gondii specific IgM was detected in any children in the
first three age classes (>1, 1 and 2–10 years old). In fact
Seroprevalence of anti Toxoplasma gondii IgM antibodies in subjects in Qatar Figure 2
Seroprevalence of anti Toxoplasma gondii IgM antibodies in subjects in Qatar. A. By age class in the whole study 
population (n = 1625). B. By age class and host sex in the 4 older age classes (11+ years old; n = 1195). C. By different regions 
of origin in the whole dataset (n = 1625). D. By regions of origin but confined to the 4 older age classes (10+ years, n = 1195).
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the youngest subject with antibodies of this class was aged
19 years. Prevalence then plateaued at 7–9% among sub-
jects over 20 years of age. Subjects from the Eastern Medi-
terranean region exhibited the highest prevalence of IgM
(10.6%) and those from Asia the lowest (2.7%). With age
class and region of origin taken into consideration, there
was also a significantly higher prevalence of IgM among
male subjects (sex* IgM, χ2
1 = 10.5, P = 0.001), although
this was not clearly reflected in the means and confidence
limits extracted from the pooled data-set (males = 6.0%,
Cl95 = 4.5 – 7.9% and females = 5.7%, Cl95 = 5.6 – 8.8%).
However, it was clearly evident when prevalence of spe-
cific IgM was calculated for subjects older than 10 years of
age (males = 10.2%, Cl95 = 7.1 – 14.1%; females = 7.0%,
Cl95 = 5.0 – 9.5%), among whom all the positives were
found.
Since no IgM was detected in the three youngest age
classes, comprising 430 subjects, the data were re-ana-
lysed excluding these groups. This yielded a significant
sex*age*presence of IgM interaction (χ2
3  = 20.4, P  =
0.0001) which is illustrated in Fig. 2B. In the youngest age
class (11–20 years old) no males were positive, whereas
prevalence was 6.6% among females. In the 30–45 year
age class prevalence of specific IgM was more than twice
as high in males compared with females (16.4 versus
6.2%). Figure 2D shows the prevalence of specific IgM
antibodies among subjects from the four regions of origin
but confined to the four older age classes, and the pattern
is much the same as when the whole data-set was ana-
lyzed (Fig. 2C).
Analysis of the whole data-set by R, fitting a GLM with a
quasibinomial error structure, confirmed the highly sig-
nificant main effects of region of origin (change in devi-
ance = 31.1, P < 0.0001 for 3 df), age (change in deviance
= 77.5, P < 0.0001, for 6 df) and sex (change in deviance
= 10.5, P < 0.0002, for 1 df), and identified also a 2-way
interaction between age and sex (change in deviance =
11.9, P = 0.02, for 6 df, residual degrees of freedom =
1614).
Discussion
The results of this study, based on serological tests, con-
firmed our expectation that toxoplasmosis is indeed
endemic in Qatar and that a substantial proportion of the
referred patients showed evidence of earlier infection
(IgG), whilst fewer had evidence of current infection
(IgM). Recent infections were detected only in subjects
who were 19 years old and older, and stabilised at 7–9%
in all the older age classes, indicating that in Doha adults
of all ages were becoming infected with T. gondii for the
first time. The rising prevalence of IgG positive subjects
with increasing age also confirmed that infections were
occurring in all age classes throughout adult life.
The study group comprised subjects that had been
referred for the TORCH series of serological/microbiologi-
cal tests as explained earlier, and for this reason they can-
not be considered as a random selection of the population
in the country. Nevertheless, since there are no other data
in the public domain on toxoplasmosis in Qatar, we con-
sidered it worthwhile to analyse the trends in prevalence
among this selected group, as a first step in a longer-term
investigation of the role of feral cats in the transmission of
toxoplasmosis among the human population in Qatar
and the associated risks to human health.
The prevalence and risk factors for the transmission of T.
gondii  vary substantially between countries and geo-
graphic regions. Toxoplasmosis is known to be present in
the Middle East with reports of infections in cats and/or
people in Egypt [27,28], Jordan [29], Jerusalem [30], Leb-
anon [31], Saudi Arabia [32-34] and Iran [35,36]. It has
been reported as particularly high among a randomly
selected proportion of the population of Kuwait [37].
In this study IgG antibodies to T. gondii were found to be
five times more common than IgM antibodies (29.8%
versus 5.8% in the study group). Clearly the overall prev-
alence of IgG antibodies, reflecting earlier infection with
T. gondii, among these referred subjects indicated that
between 1 in 3 and 1 in 4 had experienced earlier infec-
tion, and these values are broadly in line with reports
from other countries [38]. However, the changes of prev-
alence of IgG positive samples across age groups revealed
a more complex story. Almost a quarter of children less
than one year old had IgG antibodies and these were most
likely acquired from their mothers by transplacental trans-
fer [39]. By one year of age the prevalence rate had
dropped to below 5%, presumably through catabolism of
passively transferred antibodies, supporting the idea that
higher prevalence among younger children reflected
acquired maternal antibodies rather than active infection.
Prevalence then increased markedly with each successive
age class as reported previously in other studies [40],
peaking in the older subjects at over 40%. This rising trend
with age, reflects the continuing risk of infection through-
out adult life and arises from the cumulative risk of expo-
sure and infection with age in an environment where
transmission is encouraged by the high density of feral
cats.
Interestingly the age related trend in prevalence of IgG
antibodies in the combined study group, was also seen in
each of the four groups representing countries of origin of
the patients referred for examination. In each regional
group prevalence of IgG was higher among children less
than one year of age compared to those one year old, and
in each region prevalence rose with increasing age despite
some of the minor perturbations that generated the statis-Parasites & Vectors 2008, 1:39 http://www.parasitesandvectors.com/content/1/1/39
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tical interaction between region of origin and age. The
overall trend in each regional group was similar, indicat-
ing that there is ongoing and repeated exposure to T. gon-
dii in all groups.
IgM antibodies are considered to reflect active current/
recent infection [7], and not surprisingly, prevalence rates
were lower. The absence of IgM antibodies in children less
than 2 years of age is consistent with the observation that
this class is not transferred across the placenta [39], and
with the interpretation of the IgG antibodies as being
derived from the maternal circulation in the youngest
individuals. In fact the youngest subject with IgM anti-
bodies was 19 years old. These current/recent infections,
as reflected in the prevalence of IgM positives, plateaued
at about 7–9% among the older patients, and since IgM
antibody concentrations normally decline within a year of
infection [7], these results indicate that the risk of infec-
tion was very similar for each age class over 21 years of
age. There was just the one interesting exception among
30–45 year old males among whom active infections were
detected in over 16% of subjects. We cannot offer an
explanation of this finding.
Although Qataris represented the largest group in this
study, they comprised only 32.4% of the subjects for this
study, and were least likely to show evidence of earlier
infection (data not shown). The remainder were subjects
from 40 additional countries of which the next most
prominent nationality were Egyptians. Subjects from Afri-
can countries were more likely to show a positive IgG test,
whereas active/recent infections (IgM) were more com-
mon among those of Eastern Mediterranean origin, but
despite the statistically valid differences between these
groups, the differences in prevalence rates were actually
not marked (7% difference for IgM and 15% difference for
IgG, between the group with the highest and lowest in
each case). Considerably greater disparities in prevalence
between different geographical regions have been
reported previously by others [38]. It was also of interest
that after the influence of age, sex and region of origin had
been taken into account, there was no change in preva-
lence rates across the three years of the study, and this con-
trasts with reports that the prevalence of toxoplasmosis
has been steadily falling in recent decades in some coun-
tries [41-43].
Although our data cannot be considered to reflect preva-
lence rates throughout the entire population, they provide
the first quantitative data on toxoplasmosis in the human
community in the country, albeit a subset of that commu-
nity that was referred for testing. Despite the rather select
group of subjects in this study, our data clearly show that
T. gondii infections are not rare among the inhabitants of
Doha, and are likely perpetuated by the feral cat popula-
tion [6]. At this stage we cannot link the prevalence of
infections to spontaneous abortions and other known
consequences of infection with this parasite [12], and
therefore cannot assess comprehensively the full risk of
Toxoplasma  related pathologies in the local community
but we have already begun to collect relevant data to ena-
ble such analyses to be conducted in the future. Because
cats are still valued for their vital role in keeping down
rodent populations in Doha city, there are no current
plans to eliminate them. Since the principal source of
infection is not likely to be removed in the near future,
people, but especially immunocompromised individuals
and pregnant women, should be made aware of the routes
of transmission and encouraged to observe high standards
of hygiene, especially after contact with cats, soil and
before meals.
To conclude, our study has emphasised the unique epide-
miological situation in Qatar where cats outnumber
humans by two to one. Our study confirms for the first
time the presence of anti-T. gondii specific antibodies in
human populations in Qatar. Since cats are key to the
transmission of T. gondii, more extensive epidemiological
studies are warranted to assess the extent to which feral
cats actually harbour current infections and to evaluate
comprehensively the risk of transmission to other verte-
brates, including humans. The full picture will only
emerge after further studies with a broader remit are con-
ducted in the country, covering a wider range of inhabit-
ants, the meat industry, and environmental
contamination. Such studies have already been initiated.
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